AI

Exascale Labs and D. Boral ARC Acquisition I Corp. Schedule Extraordinary General Meeting of Shareholders to Approve Business Combination

Extraordinary General Meeting of BCAR Shareholders to Approve Business Combination Scheduled for Wednesday, July 29, 2026SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Exascale Labs Inc. ("Exascale" or the "Company"), a provider of next-generation AI compute infrastructure, and D. Boral ARC Acquisition I Corp. (Nasdaq: BCAR) (“BCAR”), a special purpose acquisition company, today announced that the Extraordinary General Meeting of Shareholders of BCAR (the “Meeting”) to approve the previously a

D. Boral Arc Acquisition I Corp.July 7, 20267 min read
Exascale Labs and D. Boral ARC Acquisition I Corp. Schedule Extraordinary General Meeting of Shareholders to Approve Business Combination

About this update from D. Boral Arc Acquisition I Corp.

Extraordinary General Meeting of BCAR Shareholders to Approve Business Combination Scheduled for Wednesday, July 29, 2026 SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Exascale Labs Inc. ("Exascale" or the "Company"), a provider of next-generation AI compute infrastructure, and D. Boral ARC Acquisition I Corp. (Nasdaq: BCAR) ("BCAR"), a special purpose acquisition company, today announced that the Extraordinary General Meeting of Shareholders of BCAR (the "Meeting") to approve the previously announced proposed business combination between Exascale and BCAR (the "Business Combination"), pursuant to the Business Combination Agreement between BCAR, Exascale and D. Boral ARC Merger Corporation ("Pubco"), among other parties, entered into as of January 11, 2026 (the "Business Combination Agreement"), has been scheduled for Wednesday, July 29, 2026 at 10:00 Eastern Time. At the Meeting, BCAR shareholders will be asked to consider and vote upon proposals to approve the Business Combination and related matters. BCAR shareholders of record as of Monday, July 6, 2026, are eligible to attend and vote at the Meeting. The Meeting will be held at the offices of Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154 and virtually by visiting www.proxydocs.com/BCAR. BCAR shareholders can attend using the meeting instructions set forth on their proxy cards. The Business Combination is expected to close shortly following the shareholder meeting, subject to BCAR shareholder approval and the satisfaction or waiver of certain closing conditions. Upon closing, the combined company is expected to operate as Exascale Labs Holdings Inc. and its shares are expected to trade on Nasdaq under the ticker symbol "XLAB." A definitive proxy statement containing the proposals to be presented at the Meeting has been filed with the SEC (the "Proxy Statement"); copies of the Proxy Statement have been mailed to BCAR shareholders of record as of the record date. Information about how to attend the Meeting and vote is set forth in the Proxy Statement. Every shareholder's vote is important, regardless of the number of shares held. Accordingly, BCAR requests that each shareholder complete, sign, date and return a proxy card (online or by mail) as soon as possible to ensure that the shareholder's shares will be represented at the Meeting. If any individual BCAR shareholder does not ...

View stock analysis, news, and events for D. Boral Arc Acquisition I Corp.

proxy statementbusiness combinationspecial purpose acquisition companyExascale Labs Inc.Exascale Labs Holdings Inc.Forward-Looking StatementsBCAR shareholders of record